Table 1 Baseline characteristics
From: ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial
Intervention (n = 51) | Control (n = 54) | |
|---|---|---|
Age, years | 49.9 ± 10.0 | 49.0 ± 12.2 |
Male, n (%) | 31 (60. 8) | 29 (53.7) |
Smoking, n (%) | ||
Non-smoker | 39 (76.5) | 48 (88.9) |
Ex-smoker | 8 (15.7) | 6 (11.1) |
Current smoker | 4 (7.8) | 0 (0) |
Time after KT, months | 30.7 ± 19.8 | 15.7 ± 9.5 |
Primary renal disease, n (%) | ||
Diabetes | 13 (25.5) | 13 (24.1) |
Non-diabetes | 38 (74.5) | 41 (75.9) |
Donor age, years | 46.0 ± 12.6 | 45.3 ± 14.8 |
Donor male, n (%) | 25 (49.0) | 31 (59.6) |
Donor type, n (%) | ||
Living | 24 (47.1) | 19 (35.2) |
Deceased | 27 (52.9) | 35 (64.8) |
Number of HLA mismatch | ||
Total | 3.5 ± 1.9 | 3.0 ± 1.6 |
DR | 1.1 ± 0.8 | 1.0 ± 0.6 |
PRA > 10%, n (%) | 11 (21.6) | 13 (24.1) |
Baseline laboratory data | ||
Creatinine, mg/dL | 1.1 ± 0.4 | 1.1 ± 0.3 |
eGFR, mL/min/1.73 m2 | 69.7 ± 19.0 | 74.3 ± 22.2 |